Market Overview:
The global postoperative nausea and vomiting (PONV) market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing incidence of PONV, rising number of surgical procedures, and growing demand for minimally invasive surgeries. Based on type, the serotonin antagonists segment is expected to account for the largest share of the global PONV market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as increased use of serotonin antagonists for prophylaxis against PONV and their efficacy in preventing both early-onset and delayed-onset vomiting. Based on application, hospital pharmacies are expected to account for the largest share of the global PONV market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period.
 Industry Outlook.svg)
Product Definition:
Postoperative nausea and vomiting (PONV) is a common complication after surgery. It can cause significant discomfort and distress. PONV can also delay the return of bowel function and increase the length of hospital stay.
Serotonin Antagonists:
Postoperative nausea and vomiting (PONV) is a common complication that occurs in the majority of surgical procedures. The exact cause of PONV is unknown, however research has shown that it may be caused by an interaction between two brain chemicals - serotonin and dopamine.
The drug-induced vomiting can lead to several other complications such as aspiration, pneumonia, or hip fractures which increases the mortality rate.
Steroids:
Steroids are man-made body chemicals that are extracted from animal or plant sources and used to increase the size, strength, and rate of healing of muscles, bones & other body parts. Steroids can be administered in various forms such as oral tablets, injections (intravenous), implants (injectable), transdermal patches or gels. They can also be found in their natural form in foods like meat & dairy products.
Application Insights:
Based on application, the global postoperative nausea and vomiting (PONV) market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies. The hospital pharmacy held the largest share of over 70.0% in 2017 owing to a high prevalence of surgical procedures globally coupled with rising awareness about PONV treatment options among patients post surgery is expected to drive demand for anti-nausea drugs in hospitals.
The online pharmacy segment is anticipated to witness significant growth over the forecast period due to an increase in healthcare costs along with a rise in preference for self-treatment by patients at their homes or workplaces which has resulted in increased usage of OTC medicines by consumers across various regions worldwide. Moreover, growing penetration of internet cafes and smartphones coupled with increasing disposable income levels are expected fuel demand for anti-nausea medication among consumers globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high adoption of technologically advanced products, such as antiemetic drugs and surgical procedures, coupled with a higher incidence of postoperative nausea and vomiting (PONV) among patients in this region. The prevalence rate for PONV is approximately 10% to 20% among patients undergoing general anesthesia in the U.S., which indicates that there are around 1 million cases annually [ ].
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing awareness about PONV treatment options, rising disposable income levels, improving healthcare infrastructure especially in developing countries like India and China along with an increase in medical tourism activities due to availability of affordable treatments [ ]. In addition, growing demand for minimally invasive surgeries due their perceived advantages over traditional methods will drive regional growth further on account of huge unmet clinical needs coupled with rapidly improving healthcare facilities & services at lower costs compared to developed nations [ ].
Growth Factors:
- Increasing incidence of surgery: The number of surgeries is increasing globally due to the rise in the aging population and prevalence of chronic diseases. This is expected to drive the demand for PONV drugs and therapies, thereby propelling the growth of the PONV market.
- Growing awareness about PONV: There is a growing awareness among patients and healthcare professionals about PONV and its prevention measures. This is likely to boost demand for antiemetic drugs and therapies, fueling market growth over the forecast period.
- Development of novel antiemetics: The development of novel antiemetics such as palonosetron, ramosetron, ondansetron extended-release tablets, aprepitant capsules etc., has led to their increased adoption in clinical practice for prophylaxis against postoperative nausea and vomiting. This will spur market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Postoperative Nausea and Vomiting (PONV) Market Research Report
By Type
Serotonin Antagonists, Steroids, Dopamine Antagonists, NK-1 Receptor Antagonists, Non-pharmacologic Treatment, Others
By Application
Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
By Companies
Acacia Pharma, F. Hoffmann-La Roche, Novartis, Ani Pharmaceuticals, Camurus, Sanofi, Helsinn Holding, Eisai, Merck, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Postoperative Nausea and Vomiting (PONV) Market Report Segments:
The global Postoperative Nausea and Vomiting (PONV) market is segmented on the basis of:
Types
Serotonin Antagonists, Steroids, Dopamine Antagonists, NK-1 Receptor Antagonists, Non-pharmacologic Treatment, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Acacia Pharma
- F. Hoffmann-La Roche
- Novartis
- Ani Pharmaceuticals
- Camurus
- Sanofi
- Helsinn Holding
- Eisai
- Merck
- GlaxoSmithKline
 Market Overview.svg)
Highlights of The Postoperative Nausea and Vomiting (PONV) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Serotonin Antagonists
- Steroids
- Dopamine Antagonists
- NK-1 Receptor Antagonists
- Non-pharmacologic Treatment
- Others
- By Application:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Postoperative Nausea and Vomiting (PONV) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Postoperative nausea and vomiting (PONV) is a common complication after surgery. It is characterized by intense nausea and vomiting that can last for several hours or even days after surgery. PONV may interfere with the patient's ability to eat, drink, or sleep.
Some of the key players operating in the postoperative nausea and vomiting (ponv) market are Acacia Pharma, F. Hoffmann-La Roche, Novartis, Ani Pharmaceuticals, Camurus, Sanofi, Helsinn Holding, Eisai, Merck, GlaxoSmithKline.
The postoperative nausea and vomiting (ponv) market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Postoperative Nausea and Vomiting (PONV) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Postoperative Nausea and Vomiting (PONV) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Postoperative Nausea and Vomiting (PONV) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Postoperative Nausea and Vomiting (PONV) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Postoperative Nausea and Vomiting (PONV) Market Size & Forecast, 2020-2028
4.5.1 Postoperative Nausea and Vomiting (PONV) Market Size and Y-o-Y Growth
4.5.2 Postoperative Nausea and Vomiting (PONV) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Serotonin Antagonists
5.2.2 Steroids
5.2.3 Dopamine Antagonists
5.2.4 NK-1 Receptor Antagonists
5.2.5 Non-pharmacologic Treatment
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Online Pharmacies
6.2.3 Retail Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Postoperative Nausea and Vomiting (PONV) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Postoperative Nausea and Vomiting (PONV) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Serotonin Antagonists
9.6.2 Steroids
9.6.3 Dopamine Antagonists
9.6.4 NK-1 Receptor Antagonists
9.6.5 Non-pharmacologic Treatment
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Online Pharmacies
9.10.3 Retail Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Serotonin Antagonists
10.6.2 Steroids
10.6.3 Dopamine Antagonists
10.6.4 NK-1 Receptor Antagonists
10.6.5 Non-pharmacologic Treatment
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Online Pharmacies
10.10.3 Retail Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Serotonin Antagonists
11.6.2 Steroids
11.6.3 Dopamine Antagonists
11.6.4 NK-1 Receptor Antagonists
11.6.5 Non-pharmacologic Treatment
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Online Pharmacies
11.10.3 Retail Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Serotonin Antagonists
12.6.2 Steroids
12.6.3 Dopamine Antagonists
12.6.4 NK-1 Receptor Antagonists
12.6.5 Non-pharmacologic Treatment
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Online Pharmacies
12.10.3 Retail Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Serotonin Antagonists
13.6.2 Steroids
13.6.3 Dopamine Antagonists
13.6.4 NK-1 Receptor Antagonists
13.6.5 Non-pharmacologic Treatment
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Online Pharmacies
13.10.3 Retail Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Postoperative Nausea and Vomiting (PONV) Market: Competitive Dashboard
14.2 Global Postoperative Nausea and Vomiting (PONV) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Acacia Pharma
14.3.2 F. Hoffmann-La Roche
14.3.3 Novartis
14.3.4 Ani Pharmaceuticals
14.3.5 Camurus
14.3.6 Sanofi
14.3.7 Helsinn Holding
14.3.8 Eisai
14.3.9 Merck
14.3.10 GlaxoSmithKline
